Data / Form D filings / Emerald Therapeutics, Inc.
Emerald Therapeutics, Inc.: Form D filings
Emerald Therapeutics, Inc., a health care company in Menlo Park, CA, filed 4 Form D notices with the SEC between 2010 and 2014. The latest, on February 21, 2014, reports $5.6 million sold of a $6 million offering to 5 investors.
Find out what Emerald Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3745-M EDISON WAY, Menlo Park, CA, 94025
- Phone
- (650) 257-7554
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2009
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1501852
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 21, 2014 | New notice | $6,000,005 | $5,609,997 | $390,008 | 5 | Feb 7, 2014 | sec.gov |
| Mar 29, 2012 | New notice | $2,880,440 | $1,000,000 | $1,880,440 | 4 | Mar 23, 2012 | sec.gov |
| Dec 22, 2010 | Amendment | $5,000,003 | $5,000,003 | $0 | 14 | Sep 22, 2010 | sec.gov |
| Sep 27, 2010 | New notice | $4,004,368 | $3,450,001 | $554,367 | 4 | Sep 22, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel J. Kleinbaum | Executive Officer, Director | |
| Brian R. Singerman | Director | |
| Max R. Levchin | Director | |
| Brian J. Frezza | Executive Officer, Director |
Other health care companies in California that filed recently
- Helande Innovations, Inc. $50,000 · Nov 6, 2026
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
- iPill Inc. $1.3 million · Oct 13, 2026
- White Eagle Sonic Technologies, Inc. $385,000 · Oct 13, 2026
- Digestive Disease Center, L.P. offering · Oct 8, 2026
- Xcelerated Recovery LLC $540,000 · Oct 2, 2026
- Lumati Holdings, Inc. $2.6 million · Oct 1, 2026
- Upstream Metabolics, Inc. $50,000 · Sep 29, 2026
- PFARADIGM Health, Inc. $31.1 million · Sep 28, 2026
- Alpfa Medical, Inc. $80.3 million · Sep 28, 2026
Every Form D from the week of Feb 17, 2014 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Emerald Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.